BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 12821146)

  • 1. Biomarkers of human cutaneous squamous cell carcinoma from tissues and cell lines identified by DNA microarrays and qRT-PCR.
    Dooley TP; Reddy SP; Wilborn TW; Davis RL
    Biochem Biophys Res Commun; 2003 Jul; 306(4):1026-36. PubMed ID: 12821146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-house cDNA microarray analysis of gene expression profiles involved in SCC cell lines.
    Moriya T; Seki N; Shimada K; Kato M; Yakushiji T; Nimura Y; Uzawa K; Takiguchi M; Tanzawa H
    Int J Mol Med; 2003 Oct; 12(4):429-35. PubMed ID: 12964014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of novel tumour-associated genes differentially expressed in the process of squamous cell cancer development.
    Hummerich L; Müller R; Hess J; Kokocinski F; Hahn M; Fürstenberger G; Mauch C; Lichter P; Angel P
    Oncogene; 2006 Jan; 25(1):111-21. PubMed ID: 16247483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WOX1 is essential for UVB irradiation-induced apoptosis and down-regulated via translational blockade in UVB-induced cutaneous squamous cell carcinoma in vivo.
    Lai FJ; Cheng CL; Chen ST; Wu CH; Hsu LJ; Lee JY; Chao SC; Sheen MC; Shen CL; Chang NS; Sheu HM
    Clin Cancer Res; 2005 Aug; 11(16):5769-77. PubMed ID: 16115915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoriasin (S100A7) is significantly up-regulated in human epithelial skin tumours.
    Moubayed N; Weichenthal M; Harder J; Wandel E; Sticherling M; Gläser R
    J Cancer Res Clin Oncol; 2007 Apr; 133(4):253-61. PubMed ID: 17136347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines.
    Hu L; Crowe DL; Rheinwald JG; Chambon P; Gudas LJ
    Cancer Res; 1991 Aug; 51(15):3972-81. PubMed ID: 1713123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silencing of G0/G1 switch gene 2 in cutaneous squamous cell carcinoma.
    Nobeyama Y; Watanabe Y; Nakagawa H
    PLoS One; 2017; 12(10):e0187047. PubMed ID: 29073263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratinocyte growth factor induces gene expression signature associated with suppression of malignant phenotype of cutaneous squamous carcinoma cells.
    Toriseva M; Ala-aho R; Peltonen S; Peltonen J; Grénman R; Kähäri VM
    PLoS One; 2012; 7(3):e33041. PubMed ID: 22427941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of the Axl tyrosine kinase receptor in cutaneous SCC-derived cell lines and tumours.
    Green J; Ikram M; Vyas J; Patel N; Proby CM; Ghali L; Leigh IM; O'Toole EA; Storey A
    Br J Cancer; 2006 May; 94(10):1446-51. PubMed ID: 16641895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
    Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
    Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of differentially expressed genes in cutaneous squamous cell carcinoma by microarray expression profiling.
    Nindl I; Dang C; Forschner T; Kuban RJ; Meyer T; Sterry W; Stockfleth E
    Mol Cancer; 2006 Aug; 5():30. PubMed ID: 16893473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression patterns of normal human skin, actinic keratosis, and squamous cell carcinoma: a spectrum of disease progression.
    Padilla RS; Sebastian S; Jiang Z; Nindl I; Larson R
    Arch Dermatol; 2010 Mar; 146(3):288-93. PubMed ID: 20231500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method to improve selection of molecular targets by circumventing the ADME pharmacokinetic system utilizing PharmArray DNA microarrays.
    Dooley TP; Curto EV; Reddy SP; Davis RL; Lambert G; Wilborn TW
    Biochem Biophys Res Commun; 2003 Apr; 303(3):828-41. PubMed ID: 12670486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of dysregulated genes in cutaneous squamous cell carcinoma.
    Dang C; Gottschling M; Manning K; O'Currain E; Schneider S; Sterry W; Stockfleth E; Nindl I
    Oncol Rep; 2006 Sep; 16(3):513-9. PubMed ID: 16865251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA microarrays and likelihood ratio bioinformatic methods: discovery of human melanocyte biomarkers.
    Dooley TP; Curto EV; Davis RL; Grammatico P; Robinson ES; Wilborn TW
    Pigment Cell Res; 2003 Jun; 16(3):245-53. PubMed ID: 12753397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current smoking-specific gene expression signature in normal bronchial epithelium is enhanced in squamous cell lung cancer.
    Boelens MC; van den Berg A; Fehrmann RS; Geerlings M; de Jong WK; te Meerman GJ; Sietsma H; Timens W; Postma DS; Groen HJ
    J Pathol; 2009 Jun; 218(2):182-91. PubMed ID: 19334046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and expression profiles of squamous cell carcinoma of the head and neck correlate with cisplatin sensitivity and resistance in cell lines and patients.
    Akervall J; Guo X; Qian CN; Schoumans J; Leeser B; Kort E; Cole A; Resau J; Bradford C; Carey T; Wennerberg J; Anderson H; Tennvall J; Teh BT
    Clin Cancer Res; 2004 Dec; 10(24):8204-13. PubMed ID: 15623595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
    Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
    Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK/Fn14 Interaction Confers Aggressive Properties to Cutaneous Squamous Cell Carcinoma.
    Hu G; Liang L; Liu Y; Liu J; Tan X; Xu M; Peng L; Zhai S; Li Q; Chu Z; Zeng W; Xia Y
    J Invest Dermatol; 2019 Apr; 139(4):796-806. PubMed ID: 30414907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KLF4 suppresses the tumor activity of cutaneous squamous cell carcinoma (SCC) cells via the regulation of SMAD signaling and SOX2 expression.
    Li XM; Kim SJ; Hong DK; Jung KE; Choi CW; Seo YJ; Lee JH; Lee Y; Kim CD
    Biochem Biophys Res Commun; 2019 Sep; 516(4):1110-1115. PubMed ID: 31284949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.